Murray Stahl’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-22,342
Closed -$388K 339
2023
Q3
$388K Buy
22,342
+16
+0.1% +$334 0.01% 230
2023
Q2
$465K Buy
22,326
+4,523
+25% +$98.3K 0.01% 225
2023
Q1
$419K Sell
17,803
-4,440
-20% -$119K 0.01% 229
2022
Q4
$621K Buy
22,243
+3,079
+16% +$78.7K 0.01% 194
2022
Q3
$448K Buy
19,164
+5,545
+41% +$167K 0.01% 219
2022
Q2
$460K Buy
13,619
+3,983
+41% +$140K 0.01% 224
2022
Q1
$337K Buy
9,636
+2,858
+42% +$97.7K 0.01% 278
2021
Q4
$206K Buy
+6,778
New +$221K ﹤0.01% 327

Other funds holding OGN

Murray Stahl's OGN Position: Q4 2023 in Review

Murray Stahl sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 22,342 shares — an estimated $388K sold.

Murray Stahl first reported a position in OGN in Q4 2021 and held it in 8 quarters. The position peaked at $621K in Q4 2022. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

  • Murray Stahl reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
  • Murray Stahl sold 22,342 Organon & Co shares in Q4 2023, an estimated $388K.
  • Murray Stahl first reported a position in Organon & Co in Q4 2021 and held it in 8 quarters.
  • Murray Stahl's Organon & Co position peaked at $621K in Q4 2022.
  • 719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Horizon Kinetics Asset Management's 13F filing for Q4 2023, filed 15 Feb 2024.